The Dräger PP8000 Blue offers advanced phototherapy, specifically designed to treat neonatal jaundice. It delivers optimal blue light wavelengths, ensuring the effective breakdown of bilirubin in newborns. This helps reduce jaundice symptoms and promotes faster recovery. Ideal for neonatal intensive care units (NICUs), pediatric wards, and maternity clinics, the PP8000 Blue provides efficient and safe jaundice treatment.

By offering precise light therapy, the system supports better clinical outcomes for infants with hyperbilirubinemia.

Optimal Blue Light for Fast Results

The PP8000 Blue emits blue light in the 450-460 nm range, which is proven to be most effective for bilirubin breakdown. The system delivers uniform light coverage across the baby’s body, ensuring comprehensive treatment. Healthcare providers can adjust the light intensity based on the severity of the condition, tailoring the treatment to each infant’s needs.

As a result, bilirubin levels decrease faster, helping babies recover more quickly.

Ergonomic and Easy-to-Use Design

The Dräger PP8000 Blue features an ergonomic design, making it easy to position over an infant’s crib or incubator. The system’s adjustable arm allows for precise light positioning without disturbing the baby. Its quiet operation and cool light technology keep the baby comfortable throughout the treatment, ensuring a stress-free experience.

Moreover, the system’s intuitive controls simplify setup and adjustments, making it ideal for busy neonatal units.

Safe and Gentle for Neonatal Use

Safety remains a key feature of the PP8000 Blue. It generates minimal heat, which reduces the risk of overheating or discomfort for the infant. A built-in timer tracks the duration of each session, ensuring accurate treatment times. Furthermore, the protective shield prevents UV exposure, keeping the therapy both effective and gentle.

This makes the system ideal for continuous use in delicate neonatal care environments.

Durable and Reliable for Long-Term Use

Built with high-quality materials, the Dräger PP8000 Blue delivers long-term reliability in demanding clinical settings. Its durable construction ensures consistent performance over time, requiring minimal maintenance. Thus, it provides a cost-effective solution for hospitals and clinics needing reliable jaundice treatment.

In conclusion, the Dräger PP8000 Blue offers safe, effective, and reliable phototherapy, making it an essential tool for treating neonatal jaundice efficiently.